title: Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers.
authors.affiliation: Department of Internal Medicine, University of Rostock, Germany. sebastian.klammt@medizin.uni-rostock.de
authors.forename: S
authors.initials: S
authors.lastname: Klammt
authors.forename: B
authors.initials: B
authors.lastname: Brinkmann
authors.forename: S
authors.initials: S
authors.lastname: Mitzner
authors.forename: E
authors.initials: E
authors.lastname: Munzert
authors.forename: J
authors.initials: J
authors.lastname: Loock
authors.forename: J
authors.initials: J
authors.lastname: Stange
authors.forename: J
authors.initials: J
authors.lastname: Emmrich
authors.forename: S
authors.initials: S
authors.lastname: Liebe
mesh_terms: D001802:Blood Substitutes / Q000737:chemistry*; D005079:Excipients / Q000737:chemistry*; D006801:Humans; D017114:Liver Failure, Acute / Q000097:blood*; D011485:Protein Binding; D012709:Serum Albumin / Q000032:analysis* / Q000737:chemistry*
chemical_list: D001802:Blood Substitutes; D005079:Excipients; D012709:Serum Albumin